New Search

Export article

CRISPR therapies march into clinic, but genotoxicity concerns linger

Cormac Sheridan
Published: 15 July 2021

Abstract: Following reports of collateral damage caused by CRISPR genome editing, now chromothripsis, a phenomenon associated with cancer, enters the spotlight. Following reports of collateral damage caused by CRISPR genome editing, now chromothripsis, a phenomenon associated with cancer, enters the spotlight.
Keywords: CRISPR / therapies march / genotoxicity concerns linger / march into clinic / editing / chromothripsis

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "Nature Biotechnology" .
Back to Top Top